Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis

Vascular Health and Risk Management

Volumn 4, Issue 6, 2008, Pages 1423-1432

  Aryaeian, Naheed ^a   Shahram, Farhad ^b   Djalali, Mahmoud ^a   Eshragian, Mohammad R ^a   Djazayeri, Abolghasem ^a   Sarrafnejad, Abdolfatah ^a   Naderi, Nasim ^b   Chamari, Maryam ^a   Fatehi, Fariha ^a   Zarei, Mahnaz ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood pressure; Conjugated linoleic acids; Lipid profiles; Rheumatoid arthritis; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ARYLESTERASE; C REACTIVE PROTEIN; CONJUGATED LINOLEIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTAGLANDIN E2; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; IRAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT;

ADULT; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IRAN; LINOLEIC ACIDS, CONJUGATED; LIPIDS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN E;

EID: 60249093338     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Aldred S, Sozzi T, Mudway I, et al. 2006. Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects. Proteomics, 6:1695-703.
2. Alice V, da Costa V, Vianna LM. 2005. Effect of α-tocopherol supplementation on blood pressure and lipidic profile in streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats. Clinica Chimica Acta, 351:101-4.
3. Arbonés-Mainar JM, Navarro MA, Guzmán MA, et al. 2006. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis, 189:318-27.
4. Arnett F, Edworthy SM, Bloch DA, et al. 1988. The American Rheumatoid Association 1987 revised criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum, 24:315-24.
5. Basu S, Smedman A, Vessby B. 2000b. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett, 468:33-6.
6. Basu S, Riserus U, Turpeinen A, et al. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci (Lond), 99:511-6.
7. Belton OA, Duffy A, Toomey S, et al. 2003. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation, 108:3017-23.
8. Benito P, Nelson GJ, Kelley DS, et al. 2001. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids, 36:229-36.
9. Bergamo P, Luongo D, Maurano F, et al. 2006. Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/ MpJ-Fas(lpr) mice. J Lipid Res, 47:2382-91.
10. Bergamo P, Maurano F, Rossi M. 2007. Phase 2 enzyme induction by conjugated linoleic acid improves lupus-associated oxidative stress. Free Radic Biol Med, 43:71-9.
11. Bhattacharya A, Banu J, Rahman M, et al. 2006. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem, 17:789-810.
12. Cywinski J. 1980. The Essentials in Pressure Monitoring. Boston, MA: Martinus Nijhoff, pp. 23-4.
13. De Pablo P, Dietrich T, Karlson EW. 2007. Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis Rheum, 57(Suppl 2):953-62.
14. Desroches S, Chouinard PY, Galibois I, et al. 2005. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the blood lipid profile and body composition of overweight and obese men. Am J Clin Nutr, 82:309-19.
15. Dessein PH, Stanwix AE, Joffe BI. 2002. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res, 4(Suppl 5):R5.
16. Dutta A, Dutta SK. 2003. Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr, 22(Suppl 4):258-68.
17. Gavino VC, Gavino G, Leblanc MJ. 2000. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr, 130:27-9.
18. Gey KF, Moser UK, Jordan P, et al. 1993. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr, 57:787S-97S.
19. Gordon DJ, Probstfield JL, Garrison RJ, et al. 1989. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation, 79:8-15.
20. Hannawi S, Haluska B, Marwick TH, et al. 2007. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther, 9:R116.
21. Herrera JA, Arévalo-Herrera M, Shahabuddin AK, et al. 2006. Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes. Am J Hypertens, 9(Suppl 4):381-7J.
22. Herrera JA, Shahabuddin GAKM, Ersheng C, et al. 2005. Calcium plus linoleic acid therapy for pregnancy-induced hypertension. Int J Gynaecol Obstet, 91:221-7.
23. Houseknecht KL, Vanden JP, Moya-Camarena S, et al. 1998. Dietary conjugated linoleic acid normalises impared glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun, 244:678-82.
24. Igarashi M, Miyazawa T. 2001. The growth inhibitory effect of conjugated linoleic acid on a human hepatoma cell line, HepG2, is induced by a change in fatty acid metabolism, but not the facilitation of lipid peroxidation in the cells. Biochim Biophys Acta, 1530:162-71.
25. Jarvik GP, Hatsukami TS, Carlson C, et al. 2003. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol, 23:1465-71.
26. Jarvik GP, Tsai NT, McKinstry LA, et al. 2002. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol, 22:1329-33.
27. Jeon S-M, Park YB, Kwon O-S, et al. 2005. Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: comparison with probucol. J Biochem Mol Toxicol, 19:336-46.
28. Kelly GS. 2001. Conjugated linoleic acid: A review. Altern Med Rev, 6:367-82.
29. Kim HK, Kim SR, Ahn JY, et al. 2002. Differential responses of hamsters and rats fed hig-fat or low-fat diets supplemented with conjugated linoleic acid. Nutr Res, 22:715-22.
30. Kim HK, Kim SR, Ahn JY, et al. 2005. Dietary conjugated linoleic acid reduces lipid peroxidation by increasing oxidative stability in rats. J Nutr Sci Vitaminol, 51(Suppl 1):8-15.
31. König B, Spielmann J, Haase K, et al. 2008. Effects of fish oil and conjugated linoleic acids on expression of target genes of PPARa and sterol regulatory element-binding proteins in the liver of laying hens. Br J Nutr, 21:1-9.
32. Kritchevsky D, Tepper SA, Wright S, et al. 2000. Influence of conjugated linoleic acid (CLAs) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr, 19:472S-7S.
33. Kushi LH, Folsom AR, Prineas RJ, et al. 1996. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med, 334:1156-62.
34. Lee KN, Kritchevsky D, Pariza MW. 1994. Conjugated linoleic acid and therosclerosis in rabbits. Atherosclerosis, 108:19-25.
35. Leonard SW, Joss JD, Mustacich DJ, et al. 2007. Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins. Am J Health Syst Pharm, 64(Suppl 21):2257-66.
36. Lin Y, Schuurbiers E, van der Veen S, et al. 2001. Conjugated linoleic acid isomers have differential effects on triglyceride secretion in HepG2 cells. Biochim Biophys Acta, 1533:38-46.
37. Lowell BB. 1999. PPAR gamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell, 99:239-42.
38. Metsios GS, Stavropoulos-Kalinoglou JAG, Veldhuijzen van Zanten J, et al. 2008. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology, 47(Suppl 3):239-48.
39. Miyazaki M, Kim YC, Gray-Keller MP, et al. 2000. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem, 275:30132-8.
40. Miyazaki M, Kim YC, Ntambi JM. 2001. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J Lipid Res, 42:1018-24.
41. Moya-Camarena SY, Belury MA. 1999a. Species differences in the metabolism and regulation of gene expression by conjugated linoleic acid. Nutr Rev, 57:336-40.
42. Moya-Camarena SY, Belury MA. 1999b. CLAs and PPARgamma activation. J Nutr, 129:602-6.
43. Moya-Carmarena SY, Vanden-Heuvel JP, Blanchard SG. 1999. Conjugated linoleic acid is a potent naturally occuring ligand and activator of PPARa. J Lipid Res, 40: 1426-33.
44. Munday JS, Thompson KG, James KAC. 1999. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr, 81:251-5.
45. Nagao K, Inoue N, Wang YM, et al. 2003a. The 10 trans, 12 cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun, 306:134-8.
46. Nagao K, Inoue N, Wang YM, et al. 2003b. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem Biophys Res Commun, 310:562-6.
47. Nicolosi RJ, Rogers EJ, Kritchevsky D, et al. 1997. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery, 22:266-77.
48. Nicolosi RJ, Woolfrey B, Wilson TA, et al. 2004. Decreased aortic early atherosclerosis and associated risk factors in hypercholesterolemic hamsters fed a high- or mid-oleic acid oil compared to a high-linoleic acid oil. J Nutr Biochem, 15:540-7.
49. Noone EJ, Roche HM, Nugent AP, et al. 2002. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr, 88:243-51.
50. Ntambi JM. 1999. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res, 40:1549-58.
51. Nurmohamed MT. 2007. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag, 3(Suppl 6):845-52.
52. Pai JT, Guryev O, Brown MS, et al. 1998. Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins. J Biol Chem, 273:26138-48.
53. Palacios A, Piergiacomi V, Catalá A. 2003. Antioxidant effect of conjugated linoleic acid and vitamin A during non enzymatic lipid peroxidation of rat liver microsomes and mitochondria. Mol Cell Biochem, 250(Suppl 1-2):107-13.
54. Parodi PW. 1999. Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci, 82:1339-49.
55. Peck LW, Nickel KP, Belury MA. 1998. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun, 244:678-82.
56. RaffM, Tholstrup T, Sejrsen K, et al. 2006. Diets rich in conjugated linoleic acid and vaccenic acid have no effect on blood pressure and isobaric arterial elasticity in healthy young men. J Nutr, 136(Suppl 4):992-7.
57. Rainwater DL, Mahaney MC, VandeBerg JL, et al. 2007. Vitamin E dietary supplementation significantly affects multiple risk factors for cardiovascular disease in baboons. Am J Clin Nutr, 86:597-603.
58. Rimm EB, Stampfer MJ, Ascherio A, et al. 1993. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med, 328:1450-6.
59. Riserus U, Arner P, Brismar K, et al. 2002. Treatment with dietary trans10 cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care, 25:1516-21.
60. Riserus U, Berglund L, Vessby B. 2001. Conjugated linoleic acid (CLAs) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord, 25:1129-35.
61. Roche HM, Noone E, Sewter C, et al. 2002. Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha. Diabetes, 51:2037-44.
62. Rudel LL. 1999. Atherosclerosis and conjugated linoleic acid. Br J Nutr, 81:177-9.
63. Santos-Zago LF, Botelho AP, de Oliveira AC. 2007. Supplementation with commercial mixtures of conjugated linoleic acid in association with vitamin E and the process of lipid autoxidation in rats. Lipids, 42:845-54.
64. Sanz DC, Santa-Cruz MC. 1986. Simultaneous measurement of retinol and α-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr, 380:140-4.
65. Schwenke DC, Behr SR. 1998. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ Res, 83:366-77.
66. Singh AU, Devaraj S, Jialal I. 2005. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr, 25:151-74.
67. Singhal S, Gupta R, Goyle A. 2001. Comparison of antioxidant efficacy of Svitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial. J Assoc Physicians India, 49:327-31.
68. Smedman A, Vessby B, Basu S. 2004. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (Lond), 106:67-73.
69. Smedman A, Vessby B. 2001. Conjugated linoleic acid supplementation in humans metabolic effects. Lipids, 36:773-8.
70. Stampfer MJ, Hennekens CH, Mattson JE, et al. 1993. Vitamin E consumption and the risk of coronary disease in women. New Engl J Med, 328:1444-9.
71. Stangl GI. 2000. High dietary levels of conjugated linoleic acid mixture alter hepatic glycerophospholipid CLAss profile and cholesterol-carrying serum lipoproteins of rats. J Nutr Biochem, 11:184-91.
72. Stephens NG, Parsons A, Schofield PM, et al. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet, 347:781-6.
73. Taylor CG, Zahradka P. 2004. Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. Am J Clin Nutr, 79(Suppl 6):1164S-1168S.
74. -/- mouse by conjugated linoleic acid. Biochem Soc Trans, 31:1075-9.
75. Tricon S, Burdge GC, Kew S, et al. 2004. Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr, 80:614-20.
76. Truitt A, McNeill G, Vanderhoek JY. 1999. Antiplatelet effects of conjugated linoleic acid isomers. Biochim Biophys Acta, 1438:239-46.
77. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, et al. 2000. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes, 49(Suppl 9): 1534-42.
78. Tucker JM, Townsend DM. 2005. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother, 59:380-7.
79. Valeille K, Férézou J, Amsler G, et al. 2005. A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol, 289:H652-H659.
80. Ward NC, Wu JH, Clarke MW, et al. 2007. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. J Hypertens, 25:227-34.
81. Wilson TA, Nicolosi RJ, Chrysam M, et al. 2000. Conjugated linoleic acid reduces early aortic atherosclerosis greater than linoleic acid in hypercholesterolemic hamsters. Nutr Res, 20:1795-805.
82. Zambell KL, Keim NL, Van Loan MD, et al. 2000. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids, 35:777-82.